SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Reconciliation of other significant reconciling items from segments to consolidated

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):

Three Months Ended September 30, 2019	Core Companion Animal			Other Vaccines and Pharmaceuticals			Total
Total revenue	$	26,339		$	4,898		$	31,237
Operating income (loss)	560			(367		)	193
Loss before income taxes	(367		)	(367		)	(734		)
Capital expenditures	27			66			93
Depreciation and amortization	908			329			1,237

Three Months Ended September 30, 2018	Core Companion Animal			Other Vaccines and Pharmaceuticals		Total
Total revenue	$	27,190		$	3,765	$	30,955
Operating (loss) income	(4,402		)	807		(3,595		)
(Loss) income before income taxes	(4,352		)	807		(3,545		)
Capital expenditures	20			229		249
Depreciation and amortization	823			317		1,140

Nine Months Ended September 30, 2019	Core Companion Animal			Other Vaccines and Pharmaceuticals			Total
Total revenue	$	75,771		$	13,123		$	88,894
Operating income (loss)	255			(703		)	(448		)
Loss before income taxes	(677		)	(703		)	(1,380		)
Capital expenditures	103			619			722
Depreciation and amortization	2,789			970			3,759

Nine Months Ended September 30, 2018	Core Companion Animal		Other Vaccines and Pharmaceuticals		Total
Total revenue	$	80,652	$	12,729	$	93,381
Operating income	384		95		479
Income before income taxes	347		95		442
Capital expenditures	117		944		1,061
Depreciation and amortization	2,568		905		3,473

Schedule of revenue from external customers and long-lived assets, by geographical areas

Asset information by reportable segment as of September 30, 2019 is as follows (in thousands):

As of September 30, 2019	Core Companion Animal		Other Vaccines and Pharmaceuticals		Total
Investments in unconsolidated affiliates	$	7,563	$	—	$	7,563
Total assets	202,306		21,705		224,011
Net assets	135,190		18,493		153,683

Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):

As of December 31, 2018	Core Companion Animal		Other Vaccines and Pharmaceuticals		Total
Investments in unconsolidated affiliates	$	8,018	$	—	$	8,018
Total assets	133,586		22,866		156,452
Net assets	96,129		26,280		122,409